TOT BIOPHARM
Suzhou
About TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies. Our mission is to build a leading brand name of oncology treatments trusted by patients and their families as well as medical professionals in China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $108.0M
- Funding stage: IPO
- Last round: Series B (Aug 2018)
- Ticker: hkg:1875
- Website: totbiopharm.com
- Phone: +86(0)512-6296-5186
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Oncology
Canonical: https://fsome.com/organization/tot-biopharm-138931 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.